產(chǎn)品名稱(chēng) | FITC標(biāo)記的載脂蛋白B-mRNA編碼蛋白抗體 |
英文名稱(chēng) | Anti-A1CF/FITC |
規(guī)格 | 100ul |
濃度 | 1mg/ml |
價(jià)格 | 來(lái)電可享受優(yōu)惠 |
英文名稱(chēng) Anti-A1CF/FITC
中文名稱(chēng) :FITC標(biāo)記的載脂蛋白B-mRNA編碼蛋白抗體
規(guī)格:100ul
說(shuō)明書(shū) 100ul
研究領(lǐng)域腫瘤 細(xì)胞生物 信號(hào)轉(zhuǎn)導(dǎo) 表觀(guān)遺傳學(xué)
抗體來(lái)源Rabbit
克隆類(lèi)型Polyclonal
交叉反應(yīng) Human, Mouse, Rat, Pig, Cow, Sheep,
產(chǎn)品應(yīng)用IF=1:50-200
not yet tested in other applications.
optimal dilutions/concentrations should be determined by the end user.
分子量65kDa
性 狀Lyophilized or Liquid
濃 度1mg/ml
免疫原KLH conjugated synthetic peptide derived from human A1CF
亞 型IgG
純化方法affinity purified by Protein A
儲(chǔ)存液0.01M TBS(pH7.4) with 1% BSA, 0.03% Proclin300 and 50% Glycerol.
保存條件Store at -20 °C for one year.
別 名 A1CF; A1CF_HUMAN; ACF; ACF64; ACF65; Apo B RNA editing protein; Apobec 1 complementation factor; Apobec 1 complementation factor (ACF) (ASP); APOBEC 1 stimulating protein; APOBEC1 complementation factor; APOBEC1 stimulating protein; APOBEC1-stimulating protein; APOBEC1CF; ASP; MGC163391; RP11-564C4.2.
